A man with a rare muscle-wasting condition said he feels "deflated" that a drug that improves his symptoms has not been ...

Sarepta Therapeutics ( NASDAQ: SRPT) reported a second fatality from acute liver failure in a patient treated with its gene ...

The commercial and clinical use of Elevidys was discontinued after two fatal cases of acute liver failure.

Sarepta Therapeutics said it has temporarily suspended shipments of Elevidys® (delandistrogene moxeparvovec-rokl) for ...

This year’s Dean Martin Hometown Festival brought back the sound and memories of the Steubenville native who went on to great ...

Despite setbacks, Sarepta’s gene therapy pipeline and market leadership in DMD present a high-risk, high-reward setup. Read ...

Up to 18 stallholders are to take part in Godshill Summer Fair, organised by local author Ann Blake, all in support of the ...

Sarepta Therapeutics Inc. said a second patient has died of acute liver failure after being treated with its gene therapy for ...

Notable research news last week included US biopharma Avidity Biosciences announcing a positive update on its muscular ...

The estimated cost that Belfast Trust has produced seems high and does not align with any other figures we have seen from ...

Retail investor chatter around Sarepta Therapeutics surged on Sunday after the company announced it had suspended shipments ...

After the completion of the 54th Italian-American Charity Golf Association Tournament on Saturday evening, it was time for ...